Valuation: MEDADVISO

Market Cap 8.93M 6.27M 5.59M 5.16M 4.69M 8.8M 594M 62.17M 24.49M 311M 23.53M 23.02M 985M P/E 2025
-0.76x
P/E 2026 -1.76x
Enterprise Value -466K -327K -292K -269K -245K -459K -30.98M -3.24M -1.28M -16.23M -1.23M -1.2M -51.42M EV / Sales 2025
0.92x
EV / Sales 2026 -0.05x
Free-Float
68.95%
Yield 2025 *
-
Yield 2026 -
Manager TitleAgeSince
Chief Executive Officer 46 2025-11-06
Chief Tech/Sci/R&D Officer - 2020-06-29
Corporate Secretary - 2026-04-12
Director TitleAgeSince
Director/Board Member - 2021-08-09
Chairman 67 2025-03-31
Director/Board Member 46 2025-11-06
Change 5-day change 1-year change 3-year change Capi.($)
+6.52%+8.89% - - 6.28M
-2.62%-2.97%+19.14%+46.33% 257B
-1.99%-0.84%+5.25%+12.50% 164B
+3.51%+3.46%-16.01%+62.39% 151B
+3.30%+3.61%-55.96%-8.77% 64.51B
+0.12%+2.23%-15.36%-11.09% 52.1B
+0.81%+3.10%+11.31%+65.39% 51.9B
+1.94%+1.88%+16.81%+29.99% 50.95B
-2.05%-1.00%+19.14%+58.94% 50.11B
-0.50%+2.24%+30.24%+77.62% 44.95B
Average +0.85%+3.63%+1.62%+37.03% 98.53B
Weighted average by Cap. -0.36%+3.50%+3.05%+37.89%

Financials

2025 2026
Net sales 62.99M 44.2M 39.46M 36.4M 33.07M 62.04M 4.19B 439M 173M 2.19B 166M 162M 6.95B 33.96M 23.83M 21.27M 19.62M 17.83M 33.44M 2.26B 236M 93.12M 1.18B 89.44M 87.53M 3.75B
Net income -60.21M -42.25M -37.71M -34.79M -31.61M -59.3M -4B -419M -165M -2.1B -159M -155M -6.64B -4.31M -3.02M -2.7M -2.49M -2.26M -4.24M -286M -30M -11.82M -150M -11.35M -11.11M -475M
Net Debt 7.09M 4.98M 4.44M 4.1M 3.72M 6.98M 471M 49.37M 19.45M 247M 18.68M 18.28M 782M -9.4M -6.59M -5.89M -5.43M -4.93M -9.26M -625M -65.42M -25.77M -327M -24.75M -24.22M -1.04B
Logo MEDADVISO
Adheris Health Ltd, formerly MedAdvisor Limited, is an Australia-based company engaged in offering pharmacy-driven patient engagement solutions that provide personalized patient experiences to help simplify the patient medication journey. Leveraging THRiV, a cloud-based, artificial intelligence (AI)-enabled platform, the Company enables the pharmacy with an improved pharmacy workflow and patient engagement solutions. THRiV analyzes hundreds of data points, from prescription history to socioeconomic factors, to anticipate patient needs. This technology allows the Company to deliver personalized strategies tailored to each individual. Its integrated platform provides users to manage, distribute and access medication information, including product information (PIs), consumer medicine information (CMIs) or patient leaflets (PL), instructions for use (IFUs) leaflets or videos, in real time.
Employees
-